SEC Form 4 · accession 0001209191-17-045921
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Jul 19, 2017
Accepted (ET)
Jul 21, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Jul 19, 2017 | S | 3,000 | $56.15 | D | 86,697 | D | |
| Common stockF2,F3 | Jul 19, 2017 | S | 3,000 | $56.15 | D | 86,737 | I | See footnote |
| Common stockF4 | Jul 19, 2017 | S | 500 | $56.11 | D | 86,197 | D | |
| Common stockF4,F3 | Jul 19, 2017 | S | 500 | $56.11 | D | 86,237 | I | See footnote |
| Common stockF5 | Jul 20, 2017 | S | 500 | $57.12 | D | 85,697 | D | |
| Common stockF5,F3 | Jul 20, 2017 | S | 500 | $57.12 | D | 85,737 | I | See footnote |
| Common stockF6 | Jul 20, 2017 | S | 500 | $57.13 | D | 85,197 | D | |
| Common stockF6,F3 | Jul 20, 2017 | S | 500 | $57.13 | D | 85,237 | I | See footnote |
| Common stockF7 | holding | — | — | — | 25,000 | I | See footnote | |
| Common stockF8 | holding | — | — | — | 25,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.79 to $56.72. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F4The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.85 to $56.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.58. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $56.18 to $57.59. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- F8Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.